A comparison of the effects of sudden gains and depression spikes on short- and long-term depressive symptoms in a randomized controlled trial of behavioral activation and cognitive behavioural therapy.


Journal

Journal of consulting and clinical psychology
ISSN: 1939-2117
Titre abrégé: J Consult Clin Psychol
Pays: United States
ID NLM: 0136553

Informations de publication

Date de publication:
Dec 2021
Historique:
entrez: 13 1 2022
pubmed: 14 1 2022
medline: 18 1 2022
Statut: ppublish

Résumé

The aim of this study was to examine the effects of sudden gains and depression spikes in a randomized controlled trial of cognitive behavioral therapy (CBT) and behavioral activation (BA) for depression (COBRA trial). This is a secondary analysis of 300 adults with major depressive disorder (MDD) who received CBT (n = 156) or BA (n = 144) (Richards et al., 2016). The Patient Health Questionnaire (PHQ-9) and Structured Clinical Interview Schedule (SCID) were used to measure depression symptoms at 6-, 12-, and 18-month follow-up. One-hundred and ten (37%) individuals experienced sudden gains, and 77 (26%) experienced depression spikes. There were no differences in rates of gains or spikes between treatments. Individuals with sudden gains had lower PHQ-9 scores across follow-up and were less likely to meet SCID criteria than those without a sudden gain. Generalized estimating equation (GEE) models demonstrated that individuals who had a sudden gain and were in CBT had lower PHQ-9 scores at 6 and 18 months than those in BA. Conversely, individuals who had a depression spike and were in CBT had higher PHQ-9 scores across follow-up compared to those without a depression spike and also a greater chance of meeting SCID criteria for MDD at 18 months than those who received BA. The short- and long-term impact of discontinuous change varied by type of treatment package. Identifying strategies within treatment packages and client processes that are associated with gains and spikes may help to inform treatment planning and clinical decision-making. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

Identifiants

pubmed: 35025537
pii: 2022-22669-001
doi: 10.1037/ccp0000577
doi:

Banques de données

ISRCTN
['ISRCTN27473954']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

957-969

Auteurs

Heather A O'Mahen (HA)

Mood Disorders Centre, University of Exeter.

Adele Hayes (A)

Department of Psychology, University of Delaware.

Claire Harries (C)

Greater Manchester Mental Health NHS Foundation Trust.

Asha Ladwa (A)

Mood Disorders Centre, University of Exeter.

Mohammod Mostazir (M)

College of Life and Environmental Sciences, University of Exeter.

David Ekers (D)

Tees Esk & Wear Valleys NHS Trust.

Dean McMillan (D)

Centre for Health and Population Sciences, Department of Health Sciences, Hull York Medical School.

David Richards (D)

Complex Interventions Group, University of Exeter Medical School.

Kimberly Wright (K)

Mood Disorders Centre, University of Exeter.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH